Related Experiment Video
Updated: Apr 18, 2026

12:13
Sequencing Small Non-coding RNA from Formalin-fixed Tissues and Serum-derived Exosomes from Castration-resistant Prostate Cancer Patients
Published on: November 19, 2019
7.3K
Gene expression profiling analysis of castration-resistant prostate cancer
Xuelei Wang1, Jiling Wen1, Rongbing Li1
1Department of Urology, East Hospital, Tongji University School of Medicine, Shanghai, China (mainland).
Summary
Researchers identified key genes involved in castration-resistant prostate cancer (CRPC) progression by analyzing gene expression differences between non-castrated and castrated models. These findings offer insights into CRPC development mechanisms.
Area of Science:
- Genomics and Bioinformatics
- Oncology
- Molecular Biology
Background:
- Prostate cancer is a significant global health concern.
- Metastatic prostate cancer often progresses to castration-resistant prostate cancer (CRPC).
- Understanding the molecular mechanisms driving CRPC is crucial for effective treatment.
Purpose of the Study:
- To identify differentially expressed genes (DEGs) in prostate cancer tumor samples from non-castrated versus castrated LNCaP xenograft models.
- To elucidate the molecular mechanisms underlying the development and progression of CRPC.
Main Methods:
- Downloaded and analyzed gene expression data (GSE46218) from non-castrated and castrated prostate cancer models.
- Identified DEGs using R (limma, Geoquery) and Bioconductor (RMA).
- Constructed an integrated regulatory network of DEGs, miRNAs, and TFs using Cytoscape, analyzed network motifs, and performed GO and pathway enrichment analyses.
Main Results:
- Identified 443 differentially expressed genes (DEGs).
- Constructed an integrated regulatory network revealing three motifs and two functional modules.
- Enriched Gene Ontology terms related to cell proliferation and metabolic processes, and pathways including 'pathway in cancer'.
Conclusions:
- Several identified DEGs, including CAV1, LYN, and FGFR3, are implicated in CRPC development.
- These genes likely play critical roles in the progression of castration-resistant prostate cancer.

